Advances in the treatment of HIV and chronic hepatitis C virus infection: A report from the 20<sup>th</sup> conference on retroviruses and opportunistic infections (croi 2013)

Research output: Contribution to journalArticle

Abstract

A number of direct-acting agents in advanced clinical development are poised to usher the era of combination treatment against chronic hepatitis C with regimens consisting of solely orally administered drugs. Preliminary data indicate that these drugs are very effective and more tolerable than the traditional interferon and ribavirin combination regimens. The armamentarium of antiretroviral drugs for clinical use continues to expand, albeit at a slower pace than in previous years. However, functional cure of HIV with very early initiation of antiretroviral therapy in an infant and several adolescents has been reported and has further energized the efforts to find a cure for HIV infection.

Original languageEnglish (US)
Pages (from-to)325-333
Number of pages9
JournalDrugs of the Future
Volume38
Issue number5
DOIs
StatePublished - 2013

Fingerprint

Retroviridae Infections
Opportunistic Infections
Chronic Hepatitis C
Virus Diseases
Hepacivirus
HIV
Pharmaceutical Preparations
Ribavirin
Interferons
HIV Infections
Therapeutics

Keywords

  • Antiretroviral drugs
  • Chronic hepatitis C
  • HCV entry inhibitors
  • HIV
  • Protease inhibitors

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{2dcdfefa8ab248f19c20f9ed2a8106b6,
title = "Advances in the treatment of HIV and chronic hepatitis C virus infection: A report from the 20th conference on retroviruses and opportunistic infections (croi 2013)",
abstract = "A number of direct-acting agents in advanced clinical development are poised to usher the era of combination treatment against chronic hepatitis C with regimens consisting of solely orally administered drugs. Preliminary data indicate that these drugs are very effective and more tolerable than the traditional interferon and ribavirin combination regimens. The armamentarium of antiretroviral drugs for clinical use continues to expand, albeit at a slower pace than in previous years. However, functional cure of HIV with very early initiation of antiretroviral therapy in an infant and several adolescents has been reported and has further energized the efforts to find a cure for HIV infection.",
keywords = "Antiretroviral drugs, Chronic hepatitis C, HCV entry inhibitors, HIV, Protease inhibitors",
author = "Stacey Rizza and Cummins, {Nathan W} and {El Atrouni}, W. and Badley, {Andrew David} and A. Dababneh and Zelalem Temesgen",
year = "2013",
doi = "10.1358/dof.2013.038.05.1968671",
language = "English (US)",
volume = "38",
pages = "325--333",
journal = "Drugs of the Future",
issn = "0377-8282",
publisher = "Prous Science",
number = "5",

}

TY - JOUR

T1 - Advances in the treatment of HIV and chronic hepatitis C virus infection

T2 - A report from the 20th conference on retroviruses and opportunistic infections (croi 2013)

AU - Rizza, Stacey

AU - Cummins, Nathan W

AU - El Atrouni, W.

AU - Badley, Andrew David

AU - Dababneh, A.

AU - Temesgen, Zelalem

PY - 2013

Y1 - 2013

N2 - A number of direct-acting agents in advanced clinical development are poised to usher the era of combination treatment against chronic hepatitis C with regimens consisting of solely orally administered drugs. Preliminary data indicate that these drugs are very effective and more tolerable than the traditional interferon and ribavirin combination regimens. The armamentarium of antiretroviral drugs for clinical use continues to expand, albeit at a slower pace than in previous years. However, functional cure of HIV with very early initiation of antiretroviral therapy in an infant and several adolescents has been reported and has further energized the efforts to find a cure for HIV infection.

AB - A number of direct-acting agents in advanced clinical development are poised to usher the era of combination treatment against chronic hepatitis C with regimens consisting of solely orally administered drugs. Preliminary data indicate that these drugs are very effective and more tolerable than the traditional interferon and ribavirin combination regimens. The armamentarium of antiretroviral drugs for clinical use continues to expand, albeit at a slower pace than in previous years. However, functional cure of HIV with very early initiation of antiretroviral therapy in an infant and several adolescents has been reported and has further energized the efforts to find a cure for HIV infection.

KW - Antiretroviral drugs

KW - Chronic hepatitis C

KW - HCV entry inhibitors

KW - HIV

KW - Protease inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84930541153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930541153&partnerID=8YFLogxK

U2 - 10.1358/dof.2013.038.05.1968671

DO - 10.1358/dof.2013.038.05.1968671

M3 - Article

AN - SCOPUS:84930541153

VL - 38

SP - 325

EP - 333

JO - Drugs of the Future

JF - Drugs of the Future

SN - 0377-8282

IS - 5

ER -